Works matching IS 03407004 AND DT 2021 AND VI 70 AND IP 12

Results: 26

IL-7 coupled with IL-12 increases intratumoral T cell clonality, leading to complete regression of non-immunogenic tumors.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3557, doi. 10.1007/s00262-021-02947-y

By:

Tasaki, Mamoru;
Yamashita, Midori;
Arai, Yukinori;
Nakamura, Takafumi;
Nakao, Shinsuke

Publication type:

Article

Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL.

Published in:

2021

By:

Reusing, Sarah B.;
Vallera, Dan A.;
Manser, Angela R.;
Watrin, Titus;
Bhatia, Sanil;
Felices, Martin;
Miller, Jeffrey S.;
Uhrberg, Markus;
Babor, Florian

Publication type:

Correction Notice

Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3679, doi. 10.1007/s00262-021-03024-0

By:

Filaci, Gilberto;
Fenoglio, Daniela;
Nolè, Franco;
Zanardi, Elisa;
Tomasello, Laura;
Aglietta, Massimo;
Del Conte, Gianluca;
Carles, Joan;
Morales-Barrera, Rafael;
Guglielmini, Pamela;
Scagliotti, Giorgio;
Signori, Alessio;
Parodi, Alessia;
Kalli, Francesca;
Astone, Giuseppina;
Ferrera, Francesca;
Altosole, Tiziana;
Lamperti, Giuseppina;
Criscuolo, Domenico;
Gianese, Francesco

Publication type:

Article

CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3701, doi. 10.1007/s00262-021-03008-0

By:

Reusing, Sarah B.;
Vallera, Dan A.;
Manser, Angela R.;
Vatrin, Titus;
Bhatia, Sanil;
Felices, Martin;
Miller, Jeffrey S.;
Uhrberg, Markus;
Babor, Florian

Publication type:

Article

Intersection of FcγRIIB, the microbiome, and checkpoint inhibitors in antitumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3397, doi. 10.1007/s00262-021-03004-4

By:

Baecher, Kirsten M.;
Ford, Mandy L.

Publication type:

Article

The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3693, doi. 10.1007/s00262-021-02988-3

By:

Braun, Christiane;
Schlaweck, Sebastian;
Daecke, Solveig Nora;
Brossart, Peter;
Heine, Annkristin

Publication type:

Article

Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3669, doi. 10.1007/s00262-021-02955-y

By:

Kanie, Keitaro;
Iguchi, Genzo;
Bando, Hironori;
Urai, Shin;
Shichi, Hiroki;
Fujita, Yasunori;
Matsumoto, Ryusaku;
Suda, Kentaro;
Yamamoto, Masaaki;
Fukuoka, Hidenori;
Ogawa, Wataru;
Takahashi, Yutaka

Publication type:

Article

Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3643, doi. 10.1007/s00262-021-02951-2

By:

Mair, Maximilian J.;
Ilhan-Mutlu, Ayseguel;
Pajenda, Sahra;
Kiesel, Barbara;
Wöhrer, Adelheid;
Widhalm, Georg;
Dieckmann, Karin;
Marosi, Christine;
Wagner, Ludwig;
Preusser, Matthias;
Berghoff, Anna S.

Publication type:

Article

CD38 identifies pre-activated CD8+ T cells which can be reinvigorated by anti-PD-1 blockade in human lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3603, doi. 10.1007/s00262-021-02949-w

By:

Wu, Pin;
Zhao, Lufeng;
Chen, Yongyuan;
Xin, Zhongwei;
Lin, Mingjie;
Hao, Zhixing;
Chen, Xiaoke;
Chen, Di;
Wu, Dang;
Chai, Ying

Publication type:

Article

Human hydatid cyst fluid-induced therapeutic anti-cancer immune responses via NK1.1<sup>+</sup> cell activation in mice.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3617, doi. 10.1007/s00262-021-02948-x

By:

Berriel, Edgardo;
Freire, Teresa;
Chiale, Carolina;
Rodríguez, Ernesto;
Morón, Gabriel;
Fernández-Graña, Gabriel;
Crispo, Martina;
Berois, Nora;
Osinaga, Eduardo

Publication type:

Article

Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3369, doi. 10.1007/s00262-021-02975-8

By:

Khodayari, Hamid;
Khodayari, Saeed;
Ebrahimi, Elmira;
Hadjilooei, Farimah;
Vesovic, Miko;
Mahmoodzadeh, Habibollah;
Saric, Tomo;
Stücker, Wilfried;
Van Gool, Stefaan;
Hescheler, Jürgen;
Nayernia, Karim

Publication type:

Article

Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3541, doi. 10.1007/s00262-021-02946-z

By:

Hu, Hai-Jun;
Liang, Xiu;
Li, Hai-Lang;
Wang, Huai-Yuan;
Gu, Jin-Fa;
Sun, Lan-Ying;
Xiao, Jing;
Hu, Jin-Qing;
Ni, Ai-Min;
Liu, Xin-Yuan

Publication type:

Article

Immune infiltrate diversity confers a good prognosis in follicular lymphoma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3573, doi. 10.1007/s00262-021-02945-0

By:

Tsakiroglou, Anna-Maria;
Astley, Susan;
Dave, Manàs;
Fergie, Martin;
Harkness, Elaine;
Rosenberg, Adeline;
Sperrin, Matthew;
West, Catharine;
Byers, Richard;
Linton, Kim

Publication type:

Article

Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3651, doi. 10.1007/s00262-021-02944-1

By:

Fan, Tao;
Liu, Yu;
Liu, Hengchang;
Wang, Liyu;
Tian, He;
Zheng, Yujia;
Zheng, Bo;
Xue, Liyan;
Tan, Fengwei;
Xue, Qi;
Gao, Shungeng;
Li, Chunxiang;
He, Jie

Publication type:

Article

Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3513, doi. 10.1007/s00262-021-02943-2

By:

Chen, Xi;
Fang, Liangjie;
Zhu, Yanping;
Bao, Zhang;
Wang, Qing;
Liu, Rong;
Sun, Wenjia;
Du, Haiwei;
Lin, Jing;
Yu, Bing;
Chen, Songan;
Zhou, Jianya;
Zhou, Jianying

Publication type:

Article

CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3501, doi. 10.1007/s00262-021-02941-4

By:

Lu, Wenyi;
Wei, Yunxiong;
Cao, Yaqing;
Xiao, Xia;
Li, Qing;
Lyu, Hairong;
Jiang, Yili;
Zhang, Huan;
Li, Xin;
Jiang, Yanyu;
Meng, Juanxia;
Yuan, Ting;
Zhu, Haibo;
He, Xiaoyuan;
Jin, Xin;
Sun, Rui;
Sui, Tao;
Liu, Kaiqi;
Zhao, Mingfeng

Publication type:

Article

Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3421, doi. 10.1007/s00262-021-02940-5

By:

Kono, Michihisa;
Kumai, Takumi;
Hayashi, Ryusuke;
Yamaki, Hidekiyo;
Komatsuda, Hiroki;
Wakisaka, Risa;
Nagato, Toshihiro;
Ohkuri, Takayuki;
Kosaka, Akemi;
Ohara, Kenzo;
Kishibe, Kan;
Takahara, Miki;
Katada, Akihiro;
Hayashi, Tatsuya;
Celis, Esteban;
Kobayashi, Hiroya;
Harabuchi, Yasuaki

Publication type:

Article

Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3461, doi. 10.1007/s00262-021-02939-y

By:

Rodin, William;
Sundström, Patrik;
Ahlmanner, Filip;
Szeponik, Louis;
Zajt, Kamil Kajetan;
Wettergren, Yvonne;
Bexe Lindskog, Elinor;
Quiding Järbrink, Marianne

Publication type:

Article

Megakaryoblastic leukemia: a study on novel role of clinically significant long non-coding RNA signatures in megakaryocyte development during treatment with phorbol ester.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3477, doi. 10.1007/s00262-021-02937-0

By:

Dahariya, Swati;
Raghuwanshi, Sanjeev;
Sangeeth, Anjali;
Malleswarapu, Mahesh;
Kandi, Ravinder;
Gutti, Ravi Kumar

Publication type:

Article

A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3451, doi. 10.1007/s00262-021-02936-1

By:

McGray, A. J. R.;
Eppolito, C.;
Miliotto, A.;
Singel, K. L.;
Stephenson, K.;
Lugade, A.;
Segal, B. H.;
Keler, T.;
Webster, G.;
Lichty, B.;
Kozbor, D.;
Odunsi, K.

Publication type:

Article

Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3405, doi. 10.1007/s00262-021-02933-4

By:

Salewski, Inken;
Kuntoff, Steffen;
Kuemmel, Andreas;
Feldtmann, Rico;
Felix, Stephan B.;
Henze, Larissa;
Junghanss, Christian;
Maletzki, Claudia

Publication type:

Article

The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells, and enhances anti-tumor efficacy of a model cancer vaccine in vivo.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3629, doi. 10.1007/s00262-021-02932-5

By:

Deronic, Adnan;
Nilsson, Anneli;
Thagesson, Mia;
Werchau, Doreen;
Enell Smith, Karin;
Ellmark, Peter

Publication type:

Article

Human leukocyte antigen I is significantly downregulated in patients with myxoid liposarcomas.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3489, doi. 10.1007/s00262-021-02928-1

By:

Oike, Naoki;
Kawashima, Hiroyuki;
Ogose, Akira;
Hatano, Hiroshi;
Ariizumi, Takashi;
Yamagishi, Tetsuro;
Murayama, Yudai;
Umezu, Hajime;
Imai, Chihaya;
Hayashi, Masanori;
Endo, Naoto

Publication type:

Article

Nutrient supplements from selected botanicals mediated immune modulation of the tumor microenvironment and antitumor mechanism.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3435, doi. 10.1007/s00262-021-02927-2

By:

Chen, Hui-Ming;
Sun, Linus;
Pan, Ping-Ying;
Wang, Lu-Hai;
Chen, Shu-Hsia

Publication type:

Article

A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3587, doi. 10.1007/s00262-021-02923-6

By:

Lv, Daojun;
Wu, Xiangkun;
Chen, Xi;
Yang, Shuxin;
Chen, Wenzhe;
Wang, Ming;
Liu, Yongda;
Gu, Di;
Zeng, Guohua

Publication type:

Article

COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3525, doi. 10.1007/s00262-021-02921-8

By:

Hansen, Kyle;
Kumar, Sandeep;
Logronio, Kathryn;
Whelan, Sarah;
Qurashi, Samir;
Cheng, Hsin-Yuan;
Drake, Andrew;
Tang, Margaret;
Wall, Patrick;
Bernados, David;
Leung, Ling;
Ophir, Eran;
Alteber, Zoya;
Cojocaru, Gady;
Galperin, Moran;
Frenkel, Masha;
White, Mark;
Hunter, John;
Liang, Spencer C.;
Kotturi, Maya F.

Publication type:

Article